Although antigen-specific CTLs use both perforin-mediated and FasL-mediated cytotoxicity to kill target tumor cells under physiological conditions19, 48, recent studies showed that the immune suppressive Treg cells selectively inhibit the perforin-mediated cytotoxicity without affecting T cell activation50, 51. The gene discussed is FASLG; the disease is neoplasm.